These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Tay-Uyboco J; Kwiatkowski K; Cates DB; Seifert B; Hasan SU; Rigatto H Biol Neonate; 1991; 59(4):190-200. PubMed ID: 2070020 [TBL] [Abstract][Full Text] [Related]
25. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit. Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564 [TBL] [Abstract][Full Text] [Related]
26. Limitations of theophylline in the treatment of apnea of prematurity. Sims ME; Yau G; Rambhatla S; Cabal L; Wu PY Am J Dis Child; 1985 Jun; 139(6):567-70. PubMed ID: 3890520 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea. Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants. Fang S; Sherwood RA; Gamsu HR; Marsden JT; Peters TJ; Greenough A Eur J Pediatr; 1998 May; 157(5):406-9. PubMed ID: 9625339 [TBL] [Abstract][Full Text] [Related]
29. Theophylline in treatment of apnoea of prematurity. Gupta JM; Mercer HP; Koo WW Aust Paediatr J; 1981 Dec; 17(4):290-1. PubMed ID: 7347217 [No Abstract] [Full Text] [Related]
30. [Development of plasma xanthine levels in the treatment of apnea in premature infants]. Brazier JL; Renaud H; Ribon B; Faucon G; Sassard J Therapie; 1978; 33(3):341-55. PubMed ID: 684686 [No Abstract] [Full Text] [Related]
31. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial. Skouroliakou M; Bacopoulou F; Markantonis SL J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376 [TBL] [Abstract][Full Text] [Related]
32. The efficacy of theophylline in premature infants with mixed and obstructive apnea and apnea associated with pulmonary and neurologic disease. Roberts JL; Mathew OP; Thach BT J Pediatr; 1982 Jun; 100(6):968-70. PubMed ID: 7086602 [No Abstract] [Full Text] [Related]
33. Biotransformation of theophylline to caffeine in premature newborn. Bory C; Baltassat P; Porthault M; Bethenod M; Frederich A; Aranda JV Lancet; 1978 Dec; 2(8101):1204-5. PubMed ID: 82170 [No Abstract] [Full Text] [Related]
35. Theophylline: a closer look. Frank M Neonatal Netw; 1987 Oct; 6(2):7-13. PubMed ID: 3670264 [No Abstract] [Full Text] [Related]
36. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. Boutroy MJ; Vert P; Royer RJ; Monin P; Royer-Morrot MJ J Pediatr; 1979 Jun; 94(6):996-8. PubMed ID: 448556 [No Abstract] [Full Text] [Related]
37. Methylxanthines in apnea of prematurity. Aranda JV; Turmen T Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366 [TBL] [Abstract][Full Text] [Related]
38. Theophylline and apnoeas of prematurity. Mercer H; Gupta JM Med J Aust; 1977 Nov; 2(22):725-6. PubMed ID: 611367 [No Abstract] [Full Text] [Related]
39. Paroxysmal supraventricular tachycardia during theophylline therapy in a premature infant. Loughnan PM; Mc Namara JM J Pediatr; 1978 Jun; 92(6):1016-8. PubMed ID: 660340 [TBL] [Abstract][Full Text] [Related]